Increased prevalence of hypertension in Ghana: New 2017 American College of Cardiology/American Hypertension Association hypertension guidelines application.
Journal
Journal of global health
ISSN: 2047-2986
Titre abrégé: J Glob Health
Pays: Scotland
ID NLM: 101578780
Informations de publication
Date de publication:
Dec 2020
Dec 2020
Historique:
entrez:
7
12
2020
pubmed:
8
12
2020
medline:
5
8
2021
Statut:
ppublish
Résumé
We estimated the prevalence and socio-demographic risk factors of hypertension among Ghanaian adults as per the Joint National Committee 7 and the 2017 American College of Cardiology/American Hypertension Association hypertension thresholds used for diagnosis and treatment. This cross-sectional analysis included 12 151 adults (8295 females and 3856 males) aged 18 years or older who participated in the 2014 Ghana Demographic and health Survey. Multiple logistic regression models were applied to obtain risk factors associated with hypertension as per both guidelines. Overall, 30.43% (n = 3698) and 11.48% (n = 1395) respondents had hypertension as per the 2017 ACC/AHA and JNC7 guidelines, respectively. The following factors were significant according to the 2017 ACC/AHA guideline: 55-64 years (adjusted odds ratio (aOR) = 6.42, 95% confidence interval (CI): 4.70-8.77), 45-54 years (aOR = 5.72, 95% CI = 4.70-6.85), 3544 years (aOR = 3.91, 95% CI = 3.33-4.59), and 25-34 years (aOR = 2.05, 95% CI = 1.77-2.37) age groups. Males (aOR = 1.39, 95% CI = 1.23-1.53), and urban residents (aOR = 1.18, 95% CI = 1.05-1.38). All the above risk factors were significant according to the JNC7 guideline too. Factors positively associated with only the 2017 ACC/AHA guideline included: middle income (aOR = 1.20, 95% CI = 1.02-1.42) and richest (aOR = 1.36, 95% CI = 1.10-1.69) wealth quintiles, whereas manual (aOR = 1.37, 95% CI = 1.02-1.86) was positively associated with the JNC7 guidelines only. We conclude that adopting the ACC/AHA guidelines would lead to a substantial increase in the prevalence of hypertension among Ghanaian adults, thus, hypertension prevention and control should be prioritized.
Sections du résumé
BACKGROUND
BACKGROUND
We estimated the prevalence and socio-demographic risk factors of hypertension among Ghanaian adults as per the Joint National Committee 7 and the 2017 American College of Cardiology/American Hypertension Association hypertension thresholds used for diagnosis and treatment.
METHODS
METHODS
This cross-sectional analysis included 12 151 adults (8295 females and 3856 males) aged 18 years or older who participated in the 2014 Ghana Demographic and health Survey. Multiple logistic regression models were applied to obtain risk factors associated with hypertension as per both guidelines.
RESULTS
RESULTS
Overall, 30.43% (n = 3698) and 11.48% (n = 1395) respondents had hypertension as per the 2017 ACC/AHA and JNC7 guidelines, respectively. The following factors were significant according to the 2017 ACC/AHA guideline: 55-64 years (adjusted odds ratio (aOR) = 6.42, 95% confidence interval (CI): 4.70-8.77), 45-54 years (aOR = 5.72, 95% CI = 4.70-6.85), 3544 years (aOR = 3.91, 95% CI = 3.33-4.59), and 25-34 years (aOR = 2.05, 95% CI = 1.77-2.37) age groups. Males (aOR = 1.39, 95% CI = 1.23-1.53), and urban residents (aOR = 1.18, 95% CI = 1.05-1.38). All the above risk factors were significant according to the JNC7 guideline too. Factors positively associated with only the 2017 ACC/AHA guideline included: middle income (aOR = 1.20, 95% CI = 1.02-1.42) and richest (aOR = 1.36, 95% CI = 1.10-1.69) wealth quintiles, whereas manual (aOR = 1.37, 95% CI = 1.02-1.86) was positively associated with the JNC7 guidelines only.
CONCLUSIONS
CONCLUSIONS
We conclude that adopting the ACC/AHA guidelines would lead to a substantial increase in the prevalence of hypertension among Ghanaian adults, thus, hypertension prevention and control should be prioritized.
Identifiants
pubmed: 33282222
doi: 10.7189/jogh.10.020408
pii: jogh-10-020408
pmc: PMC7688293
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
020408Informations de copyright
Copyright © 2020 by the Journal of Global Health. All rights reserved.
Déclaration de conflit d'intérêts
Competing interests: The authors completed the ICMJE Unified Competing Interest form (available upon request from the corresponding author), and declare no conflicts of interest.
Références
Am J Physiol Regul Integr Comp Physiol. 2004 Feb;286(2):R233-49
pubmed: 14707008
BMC Med. 2015 May 29;13:126
pubmed: 26021319
J Am Coll Cardiol. 2018 Jan 16;71(2):109-118
pubmed: 29146532
J Glob Health. 2018 Jun;8(1):010420
pubmed: 29899980
Glob Health Promot. 2017 Mar;24(1):14-26
pubmed: 26205104
Lancet. 2005 Jan 15-21;365(9455):217-23
pubmed: 15652604
PLoS One. 2018 Nov 7;13(11):e0205985
pubmed: 30403686
Ghana Med J. 2012 Jun;46(2 Suppl):12-7
pubmed: 23661812
Can J Cardiol. 2014 May;30(5):527-33
pubmed: 24786443
PLoS One. 2018 Apr 5;13(4):e0195340
pubmed: 29621328
Clin Exp Hypertens. 1999 Jul-Aug;21(5-6):1009-60
pubmed: 10423121
Hypertension. 2015 Jan;65(1):54-61
pubmed: 25399687
PLoS One. 2015 Sep 25;10(9):e0138991
pubmed: 26406462
Lancet. 1997 May 3;349(9061):1269-76
pubmed: 9142060
Int J Hypertens. 2018 Jan 21;2018:6959165
pubmed: 29610681
BMJ Open. 2016 Jul 27;6(7):e010085
pubmed: 27466234
J Hum Hypertens. 2015 Mar;29(3):204-9
pubmed: 25078490
Biol Sex Differ. 2012 Mar 14;3(1):7
pubmed: 22417477
BMC Cardiovasc Disord. 2013 Aug 02;13:54
pubmed: 23915151
J Fam Issues. 2010 Sep;31(9):1211-1229
pubmed: 26752799
Lancet. 2012 Dec 15;380(9859):2224-60
pubmed: 23245609
Hypertension. 2003 Dec;42(6):1206-52
pubmed: 14656957
Hypertension. 2018 Jun;71(6):e13-e115
pubmed: 29133356
PLoS One. 2015 Sep 10;10(9):e0137408
pubmed: 26355997
J Am Soc Hypertens. 2018 Nov;12(11):e45-e55
pubmed: 30416080
PLoS One. 2017 May 25;12(5):e0178334
pubmed: 28542557
Int J Hypertens. 2016;2016:3292938
pubmed: 27200184
BMJ. 2018 Jul 11;362:k2357
pubmed: 29997129
Lancet. 2002 Nov 2;360(9343):1347-60
pubmed: 12423980
J Hum Hypertens. 2018 Sep;32(8-9):608-616
pubmed: 29899377
Int J Hypertens. 2018 Aug 9;2018:5610725
pubmed: 30174948
PLoS One. 2016 Oct 12;11(10):e0162753
pubmed: 27732601
Lancet. 2017 Jan 7;389(10064):37-55
pubmed: 27863813
JAMA. 2018 Jan 9;319(2):115-116
pubmed: 29242891
East Afr Med J. 2001 Apr;78(4):180-4
pubmed: 12002067
Matern Health Neonatol Perinatol. 2018 Sep 5;4:17
pubmed: 30202536
J Hum Hypertens. 2017 Oct;31(10):620-626
pubmed: 28639611
Curr Hypertens Rep. 2013 Aug;15(4):321-30
pubmed: 23749317
BMJ Open. 2017 Jun 8;7(6):e014349
pubmed: 28600362